Orthopedic Biologics Supplier Serving Fresno, California

Vendor qualification for West Coast orthopedic groups

Orthopedic surgery centers and multi-physician groups generally route a new biologics vendor through a credentialing or supply committee before a single surgeon can order independently, particularly where the center carries its own accreditation. This process usually starts with a request for the same documents regardless of supplier: a certificate of analysis for the lot in question, a donor eligibility summary, and a plain description of how the tissue is recovered, tested, and released before shipment. Precision Biologics treats this request as the starting point for any new Fresno account rather than something handled after the fact.

NPI verification and ordering access

Every account is confirmed against a practice or physician's National Provider Identifier in the NPPES registry before pricing or ordering access is released. This step applies identically to a Fresno surgery center or a solo orthopedic practice, and it is the reason Precision Biologics does not list prices publicly: pricing becomes available only once an account has been verified as a licensed professional.

Cold-chain shipping to Central California

Cryopreserved Wharton's jelly and exosome products are shipped overnight on dry ice in validated containers to any destination, and a Fresno practice should plan for someone to be on hand to move the shipment into -80 degree C storage as soon as it arrives, since transit conditions on the West Coast are not something a supplier can control after the package leaves the facility. Lyophilized products are shelf-stable and give practices more flexibility in scheduling deliveries around surgery days.

Documentation and verifying with the state board

Before shipping a first order, Precision Biologics provides the lot release record, sterility testing documentation, and donor eligibility summary for that lot, along with access to a peer-to-peer call focused on the paperwork rather than clinical decisions. Orthopedic practices should separately confirm their own licensure status and scope of practice with the Medical Board of California and their own counsel, since Precision Biologics does not advise on intended use, dosing, or procedures. Account setup support is available once NPI verification is complete.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.